Abstract:Background Despite the high efficiency of surgical methods in correction of bladder outlet obstruction (BOO) caused by benign prostatic hyperplasia (BPH), a significant proportion of patients (up to 35%) remains after surgery with impaired contractile function of the bladder and lower urinary tract symptoms (LUTS). Both are consequences of structural and functional changes of the detrusor due to long-term exposure to obstructive factor. Today there is a lack of systematic reviews that provide a specialist with an integrative conception of pathological changes in the bladder wall caused by BPH associated prolonged BOO and evidence based methods of detrusor rehabilitation. The objective: systematization of modern conceptions about structural and functional changes in the bladder of patients with BPH caused by prolonged BOO, and methods of their correction. Materials and methods. An analytical review of the literature covering pathogenesis of bladder remodeling due to BPH associated long-term BOO and methods of bladder rehabilitation was performed. Literature sources were searched in PubMed, Google Scholar, Scopus and Web of Science databases by keywords. The search depth was 40 years. 74 relevant publications were selected for analysis. Results. Bladder remodeling due to obstructive factor is a complex staged process that involves all layers of the wall at the tissue, cellular and subcellular levels, affecting not only the executive structures (urothelium, smooth-muscle syncytium, fibrous connective tissue matrix), but also the system metabolism. Depending on the nature of the changes, there are 3 stages of this process: compensation, subcompensation and decompensation. In the compensatory stage, an increase of the load on the bladder leads to hypertrophy of smooth muscle fibers. At the same time, there is a reorganization of the vascular bed – neoangiogenesis, which should provide increased energy needs of muscles. In the stage of subcompensation, vicarious hypertrophy and neoangiogenesis cease. The most prominent disorders of the structure and function of the bladder are observed in the stage of decompensation. It includes a number of pathological processes: hypoxia, anaerobic metabolism, oxidative stress, inflammation, changes in the paracrine environment (increased levels of HIF-1α, vascular endothelial growth factor (VEGF) and angiopoietin-1). It is characterized by progressive loss of contractile function of the detrusor due to the death of smooth muscle cells and neurons, deterioration of viscoelastic characteristics of the bladder wall due to excessive collagen synthesis by fibroblasts, loss of barrier properties of the mucous membrane due to dystrophy. It was found that the severity of these pathological changes correlates with the severity of LUTS in patients who underwent surgery for BPH. The current arsenal of measures for bladder rehabilitation is quite diverse and includes periodic sterile catheterization, pharmacotherapy (cholinesterase inhibitors, antioxidants), physiotherapy (electrical stimulation, muscles training) and plastic surgery. However, there is still a lack of high-level studies to prove their effectiveness in patients who have undergone prostate surgery for BOO caused by BPH. Conclusions. Persistence of LUTS in patients who have undergone prostate surgery due to BOO may be caused by bladder decompensation. Long-term bladder decompensation due to prolonged exposure to obstructive factor is a complex process that includes decreased contractile activity, deterioration of the viscoelastic characteristics of the bladder, and impaired mucosal barrier function. Further research is needed to develop an effective bladder rehabilitation protocol.

Research Progress on Noninvasive Diagnostic Methods of Benign Prostatic Hyperplasia and Bladder Outlet Obstruction

The value of pressure-flow study in diagnosis for patients with benign prostatic hyperplasia

Relationship Between Bladder Outlet Obstruction and Serum Prostatic Specific Antigen in Patients with Benign Prostatic Hyperplasia

Ultrasonic Measurement of Intravesical Prostatic Protrusion in Benign Prostatic Hyperplasia Patients

Six Novel Minimally Invasive Therapies for Benign Prostatic Hyperplasia

Changes of Basic Fibroblast Growth Factor in Bladder Smooth Muscle in Patients with Bladder Outlet Obstruction Induced by Benign Prostatic Hyperplasia

Diagnosis of bladder outlet obstruction in men using a near-infrared spectroscopy instrument as the noninvasive monitor for bladder function.

The Clinical Significance of Urodynamic Study of the Preoperative Diagnosis and Treatment about Benign Prostate Hyperplasia and Postoperative Prevention of Bladder Spasm

Correlation between intravesical protrusion of prostate and bladder outlet obstruction in benign prostatic hyperplasia

The diagnostic value of non-invasive methods for diagnosing bladder outlet obstruction in men with lower urinary tract symptoms: A meta-analysis.

[Applying Bladder Outlet Obstruction Number to Predict Bladder Outlet Obstruction of Benign Prostatic Hyperplasia].

[Bladder Outlet Obstruction Index Alone is Not Reliable for the Diagnosis of Benign Prostate Hyperplasia].

Study on the relationship between the degree of intravesical prostatic protrusion and the severity of bladder outlet obstruction

Non-Invasive Clinical Parameters for the Prediction of Urodynamic Bladder Outlet Obstruction: Analysis Using Causal Bayesian Networks

[Analysis of the Diagnostic Criteria of Bladder Outlet Obstruction in Benign Prostatic Hyperplasia].

The accuracy of intravesical prostatic protrusion for diagnosing bladder outlet obstruction: A meta-analysis

A clinical study of urodynamic data with indefinite P-F findings in BPO

A retrospection of 1345 cases of inpatients with Benign prostatic hyperplasia in the past 10 years

Bladder Decompensation in Patients with Benign Prostatic Hyperplasia: Causes, Complications, Rehabilitation

Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement.

The Clinical Analysis Of Urodynamic Test In Treating Bph Complicated With Neurogenic Disease